Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Department of Health and Human Services (HHS)
Biotech
Compass, Usona and Transcend score priority vouchers amid psychedelic push
The FDA is awarding national priority vouchers to Compass, Usona and Transcend for their psychedelic treatments.
Will Maddox
Apr 24, 2026 3:51pm
Fierce Healthcare
States' lawsuit against RFK Jr.'s HHS overhaul moves forward
Apr 9, 2026 7:30am
Fierce Healthcare
White House floats 12.5% budget cut for HHS in FY2027
Apr 3, 2026 2:00pm
NIH grants generated a 250% return on $36.6B investment in 2025
Mar 11, 2026 11:11am
Fierce Pharma
FDA approves leucovorin without clinical trial—but not for autism
Mar 10, 2026 9:00am
HHS bans Anthropic's Claude AI tool
Mar 2, 2026 5:17pm